JWS
KNSA icon

Juncture Wealth Strategies’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Juncture Wealth Strategies’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
17,824
+8,354
+88% +$433K 0.3% 60
2026
Q1 		$456K Buy
9,470
+1,324
+16% +$58.7K 0.15% 81
2025
Q4 		$336K Buy
8,146
+1,282
+19% +$51.4K 0.11% 94
2025
Q3 		$267K Buy
+6,864
New +$223K 0.09% 112

Other funds holding KNSA

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
FEG
Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Juncture Wealth Strategies's KNSA Position: Q2 2026 in Review

Juncture Wealth Strategies increased its Kiniksa Pharmaceuticals (KNSA) stake by 88% in Q2 2026, buying an estimated $433K and bringing the position to 17,824 shares worth $1.14M. The position accounts for 0.3% of the portfolio, ranked #60.

Juncture Wealth Strategies first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 43 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Juncture Wealth Strategies held 17,824 shares of Kiniksa Pharmaceuticals worth $1.14M as of Q2 2026.
  • Juncture Wealth Strategies bought 8,354 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $433K.
  • Kiniksa Pharmaceuticals made up 0.3% of Juncture Wealth Strategies's portfolio in Q2 2026, its #60 holding.
  • Juncture Wealth Strategies first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 43 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.